(Q43898530)

English

CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer

scientific article published in November 2016

In more languages
default values for all languages
No label defined

No description defined

Statements

CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer (English)
Shawn F Johnson
Cristina Cruz
Ann Katrin Greifenberg
Benjamin Primack
Andrea J Bernhardy
Rhiannon Coulson
Jean-Bernard Lazaro
Bose Kochupurakkal
Lisa A Moreau
Maurizio Scaltriti
José Baselga
Andrea L Richardson
Scott J Rodig
Alan D D'Andrea
Neil Johnson
Geoffrey I Shapiro

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit